Barton G. Weick

544 total citations
16 papers, 470 citations indexed

About

Barton G. Weick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Barton G. Weick has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Barton G. Weick's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Barton G. Weick is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Barton G. Weick collaborates with scholars based in United States. Barton G. Weick's co-authors include Judith R. Walters, Raymond M. Quock, Sue Ritter, Thomas N. Chase, A. Horita, Justine R. Smith, Zvi Susel, Thomas M. Engber, Joanne H. Carlson and Debra A. Bergstrom and has published in prestigious journals such as Brain Research, Life Sciences and Neurobiology of Aging.

In The Last Decade

Barton G. Weick

16 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barton G. Weick United States 11 322 153 139 49 41 16 470
A D Crocker Australia 11 206 0.6× 100 0.7× 74 0.5× 42 0.9× 51 1.2× 17 420
Kopin Ij United States 11 202 0.6× 122 0.8× 119 0.9× 75 1.5× 49 1.2× 23 430
Per Johansson Sweden 10 285 0.9× 110 0.7× 106 0.8× 37 0.8× 12 0.3× 15 446
Enrica Mosca Italy 10 397 1.2× 182 1.2× 60 0.4× 67 1.4× 38 0.9× 15 503
Elizabeth J. Cline United States 14 451 1.4× 256 1.7× 89 0.6× 68 1.4× 20 0.5× 16 554
Masashi Sasa Japan 11 325 1.0× 176 1.2× 48 0.3× 42 0.9× 27 0.7× 22 437
David Lozovsky United States 9 203 0.6× 99 0.6× 39 0.3× 59 1.2× 59 1.4× 12 386
Maggie D. Lalies United Kingdom 12 315 1.0× 247 1.6× 59 0.4× 75 1.5× 51 1.2× 17 492
Carole A. Wilmot United States 11 270 0.8× 160 1.0× 31 0.2× 87 1.8× 45 1.1× 16 466
Hiroo Kuroda Japan 8 270 0.8× 131 0.9× 26 0.2× 64 1.3× 54 1.3× 16 391

Countries citing papers authored by Barton G. Weick

Since Specialization
Citations

This map shows the geographic impact of Barton G. Weick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barton G. Weick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barton G. Weick more than expected).

Fields of papers citing papers by Barton G. Weick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barton G. Weick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barton G. Weick. The network helps show where Barton G. Weick may publish in the future.

Co-authorship network of co-authors of Barton G. Weick

This figure shows the co-authorship network connecting the top 25 collaborators of Barton G. Weick. A scholar is included among the top collaborators of Barton G. Weick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barton G. Weick. Barton G. Weick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sethy, Vimala H., et al.. (1993). Intravenous administration of L-kynurenine to rhesus monkeys: Effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid. Neuropharmacology. 32(5). 467–472. 23 indexed citations
2.
Engber, Thomas M., Zvi Susel, Barton G. Weick, Judith R. Walters, & Thomas N. Chase. (1992). Effects of chronic Levodopa on D1 and D2 receptor-mediated striatal output. Neurochemistry International. 20. 255–260. 4 indexed citations
3.
Duncan, Mark W., et al.. (1992). 2-Amino-3-(methylamino)propanoic acid (BMAA) bioavailability in the primate. Neurobiology of Aging. 13(2). 333–337. 29 indexed citations
4.
Weick, Barton G., Thomas M. Engber, Zvi Susel, Thomas N. Chase, & Judith R. Walters. (1990). Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration. Brain Research. 523(1). 16–22. 52 indexed citations
5.
Walters, Judith R., Joanne H. Carlson, Barton G. Weick, & Debra A. Bergstrom. (1988). Neurophysiological Examination of the Role of D-1 Dopamine Receptors in the Regulation of Neuronal Activity in the Basal Ganglia. Advances in experimental medicine and biology. 235. 145–158. 2 indexed citations
6.
Carlson, Joanne H., Debra A. Bergstrom, Barton G. Weick, & Judith R. Walters. (1987). Neurophysiological investigation of effects of the D‐1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Synapse. 1(5). 411–416. 37 indexed citations
7.
Weick, Barton G. & Judith R. Walters. (1987). D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway. Neuropharmacology. 26(6). 641–644. 24 indexed citations
9.
Weick, Barton G. & Sue Ritter. (1986). Stimulation of insulin release and suppression of feeding by hepatic portal glucagon infusion in rats. Physiology & Behavior. 38(4). 531–536. 8 indexed citations
10.
Weick, Barton G. & Sue Ritter. (1986). Dose-related suppression of feeding by intraportal glucagon infusion in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 250(4). R676–R681. 22 indexed citations
11.
Weick, Barton G., Sue Ritter, & Richard McCarty. (1983). Plasma catecholamines in fasted and sucrose supplemented rats. Physiology & Behavior. 30(2). 247–252. 21 indexed citations
12.
Weick, Barton G. & Sue Ritter. (1983). Fasting reduces cardiac beta-adrenergic receptor concentration and ornithine decarboxylase activity in rats. Journal of the Autonomic Nervous System. 7(2). 179–183. 5 indexed citations
13.
Weick, Barton G., Sue Ritter, & Robert C. Ritter. (1980). Plasma catecholamines: Exaggerated elevation is associated with stress susceptibility. Physiology & Behavior. 24(5). 869–874. 6 indexed citations
14.
Quock, Raymond M. & Barton G. Weick. (1979). p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia. Journal of Pharmacy and Pharmacology. 31(1). 27–32. 15 indexed citations
15.
Quock, Raymond M. & Barton G. Weick. (1978). Tryptamine-induced drug effects insensitive to serotoninergic antagonists: evidence of specific tryptaminergic receptor stimulation?. Journal of Pharmacy and Pharmacology. 30(1). 280–283. 41 indexed citations
16.
Smith, Justine R., et al.. (1976). Effects of thyrotropin-releasing hormone (TRH) microinjected into various brain areas of conscious and pentobarbital-pretreated rabbits. Life Sciences. 19(11). 1687–1692. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026